Whitepaper: Strategies to Maximize Customer Engagement
Simplify to amplify: “Declutter” your current Customer Engagement approach to maximize value
In today's rapidly evolving healthcare landscape, effective customer engagement strategies are pivotal for success, and now more than ever, pharmaceutical companies must adapt to maximize value.
Download this insightful whitepaper authored by Putnam's Antonio Iervolino, Partner, and Karan Raje, Principal, as they delve into the shifting dynamics of customer engagement within the healthcare ecosystem. They examine the challenges faced by current engagement models showcasing a thorough analysis of recent product launches and not only offer strategic focus areas for improvement but propose actionable strategies to enhance brand performance and launch success, while amplifying the customer experience.
Download using the form below
Key Topics of Discussion:
- Evolving Customer Dynamics: Explore how clinicians, payers, and patients have evolved in their expectations and transformed their interactions with pharmaceutical companies, emphasizing the increasing need for integration, data-driven insights, and digital connectivity.
- Challenges in Current Engagement Models: Understand the key obstacles hindering effective engagement, including underdeveloped capabilities, inadequate investment, and a lack of alignment with evolving customer needs.
- Opportunities for Optimization: Discover actionable insights to bridge the gap between current engagement strategies and customer requirements, emphasizing reallocating resources to high-impact areas along the patient journey and adopting a zero-based approach to investment.
- Focus Areas for Improvement: Learn about critical focus areas for enhancing pharmaceutical customer engagement, including developing ecosystem intelligence, aligning investments with customer needs, and augmenting frontline impact through a purposeful integration of technology and back-office team.
Dive in today: Download this whitepaper produced by Putnam, an Inizio Advisory company, to gain actionable strategies for optimizing your customer engagement and go-to-market approach with confidence.
About the Author
-
Partner Putnam, an Inizio Advisory company Antonio leads the Commercial European team at Putnam, advising biopharmaceutical companies across a range of strategy and transformation topics including launch and organizational strategy, change management, and portfolio development and optimization. He has partnered with clients across several therapeutic areas and led transformation programs at both HQ and affiliate level. Prior to joining Putnam, Antonio was in senior roles at IQVIA and Mundipharma (pricing and access, commercial operations). At IQVIA, he led the EMEA Brand and Commercial Strategy practice as well as global consulting in the Nordics, UK, Ireland, and BENELUX. He has a background in business management and economics and executive education in R&D strategy (INSEAD) and Innovation (MIT).
-
Principal Putnam, an Inizio Advisory company Karan focuses on commercial strategy for leading US and European pharmaceutical and biotech clients providing them with actionable recommendations for pipeline and in-line products. His core areas of focus are new product commercialization, go-to-market strategy, portfolio development and optimization, and organizational strategy. Karan’s experience spans across a range of therapeutic areas, with recent engagements focused primarily on hematology, (immuno)-oncology, rare diseases, and neurology. Prior to joining Putnam, Karan focused on R&D and Product Design at Vasoptic Medical, a clinical-stage med-tech start-up developing a novel imaging platform for early diagnosis of ophthalmic diseases. Karan holds a B.S. in Bioengineering from the University of Maryland, an M.Eng in Biomedical Engineering from Cornell University, and an MBA from London Business School.
-
Putnam, an Inizio Advisory company, is a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. For more than 30 years, our rigorous, bespoke approach and globally diverse team have delivered unrivaled depth across therapeutic areas, business functions, geographic markets, healthcare sectors, and technology platforms to maximize the human impact and commercial success of client innovations. https://www.putassoc.com/
